Loss of this capacity produces increased uptake in other metabolically less suited tissues such as liver, muscle, and pancreatic beta cells where harmful effects include fatty liver, dyslipidemia, and loss of insulin sensitivity and insulin secretion. The gene discussed is INS; the disease is metabolic syndrome.